Autopsy report · NCT03259893

Secondary Prevention of Atrial Fibrilation

“Initially suspended due to COVID-19 policies, it will not be possible to restart.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 months before it started.
• Ran for about 2 years 3 months before it stopped.
• 3 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Boston Medical Center

Sponsor type

University, hospital or other

Conditions

Atrial Fibrillation; Risk Factors; Risk Reduction Behavior

Interventions

AliveCor mobile ECG cardiac monitor; AF Program; Standard of care

Participants

3

Sites

1

Countries

United States

Trials that died the same way

• The Norwegian Prednisolone in Early Psychosis Study
  “Stopped because of COVID 19 pandemic” (62% match in meaning)
• The SmokeFree App Smoking Cessation Study
  “Suspended due to COVID19 pandemic.” (60% match in meaning)
• Lifestyle, Exercise and Diet: The LEAD Study
  “Due to COVID-19, recruitment and enrollment was suspended and never resumed. COVID-related changes have been made to the clinical program which houses our intervention, and we could not compare new participants with our previous cohort.” (60% match in meaning)
• Dose-response of Talus Mobilizations
  “Suspended due to the covid-19 pandemic.” (60% match in meaning)
• A Safety and Tolerability Study of ILB® in Patients With Amyotrophic Lateral Sclerosis (ALS)
  “Study initially suspended due to COVID-19 Pandemic- treatment stopped - never reopened to recruitment..” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.